...
首页> 外文期刊>Experimental dermatology >Immunophenotyping of the human bulge region: the quest to define useful in situ markers for human epithelial hair follicle stem cells and their niche.
【24h】

Immunophenotyping of the human bulge region: the quest to define useful in situ markers for human epithelial hair follicle stem cells and their niche.

机译:人类隆起区的免疫表型分析:寻求为人类上皮毛囊干细胞及其利基定义有用的原位标记。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Since the discovery of epithelial hair follicle stem cells (eHFSCs) in the bulge of human hair follicles (HFs) an important quest has started: to define useful markers. In the current study, we contribute to this by critically evaluating corresponding published immunoreactivity (IR) patterns, and by attempting to identify markers for the in situ identification of human eHFSCs and their niche. For this, human scalp skin cryosections of at least five different individuals were examined, employing standard immunohistology as well as increased sensitivity methods. Defined reference areas were compared by quantitative immunohistochemistry for the relative intensity of their specific IR. According to our experience, the most useful positive markers for human bulge cells turned out to be cytokeratin 15, cytokeratin 19 and CD200, but were not exclusive, while beta1 integrin and Lhx2 IR were not upregulated by human bulge keratinocytes. Absent IR for CD34, connexin43 and nestin on human bulge cells may be exploited as negative markers. alpha6 integrin, fibronectin, nidogen, fibrillin-1 and latent transforming growth factor (TGF)-beta-binding protein-1 were expressed throughout the connective tissue sheath of human HFs. On the other hand, tenascin-C was upregulated in the bulge and may thus constitute a component of the bulge stem cell niche of human HFs. These immunophenotyping results shed further light on the in situ expression patterns of claimed follicular 'stem cell markers' and suggest that not a single marker alone but only the use of a limited corresponding panel of positive and negative markers may offer a reasonable and pragmatic compromise for identifying human bulge stem cells in situ.
机译:自从在人类毛囊(HFs)凸起中发现上皮毛囊干细胞(eHFSC)以来,一项重要的任务便已开始:定义有用的标记物。在当前的研究中,我们通过严格评估相应的已发表的免疫反应(IR)模式,并尝试鉴定用于人类eHFSCs及其位点的原位鉴定的标记物,为这一目标做出了贡献。为此,采用标准的免疫组织学以及提高敏感性的方法,对至少五个不同个体的人头皮皮肤冷冻切片进行了检查。通过定量免疫组织化学比较确定的参考区域的特异性IR的相对强度。根据我们的经验,对于人类膨出细胞最有用的阳性标记物是细胞角蛋白15,细胞角蛋白19和CD200,但不是唯一的,而人类膨化角质形成细胞并未上调beta1整合素和Lhx2 IR。人鼓胀细胞上CD34,连接蛋白43和巢蛋白缺失的IR可以用作阴性标记。 α6整联蛋白,纤连蛋白,胶原蛋白,纤连蛋白-1和潜在转化生长因子(TGF)-β结合蛋白-1在人类HF的结缔组织鞘中表达。另一方面,腱生蛋白-C在凸起中被上调,因此可能构成人类HF凸起的干细胞生态位的一个组成部分。这些免疫表型结果进一步阐明了所要求的滤泡“干细胞标记”的原位表达模式,并表明并非单独使用单个标记,而仅使用有限数量的相应的阳性和阴性标记可能会提供合理而务实的折衷方案。原位鉴定人膨大的干细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号